Third degree atrioventricular block associated with treatment with rivastigmine transdermal patch.

Author: ChristophersenThomas B, KnudtzenFredrikke C

Paper Details 
Original Abstract of the Article :
Rivastigmine transdermal patch is indicated for patients with Alzheimer's disease and dementia with Parkinson's disease. Rivastigmine, an acetylcholinesterase inhibitor, has several common adverse effects, mainly involving the gastrointestinal tract, but few cardiovascular adverse effects have been ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627713/

データ提供:米国国立医学図書館(NLM)

Rivastigmine: A Desert Oasis with Unexpected Hazards

Rivastigmine, an acetylcholinesterase inhibitor, is a commonly used medication for treating Alzheimer's disease and dementia with Parkinson's disease. This report presents two cases of patients who developed third-degree atrioventricular block, a serious heart condition, after starting treatment with rivastigmine. It's like a desert traveler discovering a lush oasis, only to realize that the water is contaminated and poses a health risk. This report highlights the importance of being aware of potential side effects, even for medications that are generally considered safe.

Rivastigmine: A Double-Edged Sword

The report emphasizes the importance of careful monitoring of patients taking rivastigmine, particularly those with pre-existing heart conditions. It's a reminder that even seemingly safe medications can have unexpected side effects, and it's crucial to be vigilant for any warning signs. It's like a desert traveler, cautious of hidden dangers, navigating the terrain of medication with care and attention to detail.

Navigating the Desert of Medication: Staying Safe and Informed

This report highlights the importance of open communication between patients and their healthcare providers. Patients should inform their doctors about any pre-existing conditions or concerns, and physicians should be aware of potential side effects of medications, even those that are commonly prescribed. It's a journey through the desert of medication, where open communication and shared understanding are essential for a safe and successful outcome.

Dr.Camel's Conclusion

This report serves as a reminder that even seemingly safe medications can have unexpected side effects. It highlights the importance of careful monitoring and open communication between patients and their healthcare providers. Remember, the desert of medication can be unpredictable, and staying informed and vigilant is crucial for a safe and successful journey.

Date :
  1. Date Completed 2013-04-24
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

23610582

DOI: Digital Object Identifier

PMC3627713

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.